Search


Current filters:



Start a new search
Add filters:

Use filters to refine the search results.


Results 1-8 of 8 (Search time: 0.003 seconds).
  • previous
  • 1
  • next
Item hits:
PreviewIssue DateTitleAuthor(s)
2004Inhibition of generation of cytotoxic T lymphocyte activity by a CCL19/macrophage inflammatory protein (MIP)-3beta antagonistPilkington, K.; Clark-Lewis, I.; McColl, S.
2005Cytoplasmic ATP-sensing domains regulate gating of skeletal muscle ClC-1 chloride channelsBennetts, B.; Rychkov, G.; Ng, H.; Morton, C.; Stapleton, D.; Parker, M.; Cromer, B.
2003Nova regulates GABA(A) receptor gamma 2 alternative splicing via a distal downstream UCAU-rich intronic splicing enhancerDredge, B.; Darnell, R.
2001Peptide insertions in domain 4 of hbc, the shared signalling receptor subunit for GM-CSF, IL3 and IL5, induce ligand-independent activationJones, K.; Bagley, C.; Butcher, C.; Barry, S.; Vadas, M.; D'Andrea, R.
2004Role of N- and C-terminal residues of insulin-like growth factor (IGF)-binding protein-3 in regulating IGF complex formation and receptor activationYan, X.; Forbes, B.; McNeil, K.; Baxter, R.; Firth, S.
2008Re-evaluating the roles of proposed modulators of mammalian target of rapamycin complex 1 (mTORC1) signalingWang, X.; Fonseca, B.; Tang, H.; Liu, R.; Elia, A.; Clemens, M.; Bommer, U.; Proud, C.
2009The structure of an interdomain complex that regulates talin activityGoult, B.; Bate, N.; Anthis, N.; Wegener, K.; Gingras, A.; Patel, B.; Barsukov, I.; Campbell, I.; Roberts, G.; Critchley, D.
2001Contribution of residues A54 and L55 of the human insulin-like growth factor-II (IGF-II) A domain to Type 2 IGF receptor binding specificityForbes, B.; McNeil, K.; Scott, C.; Surinya, K.; Cosgrove, L.; Wallace, J.